{"schema_version":"1","generated_at":"2026-11-06T10:28:57.766Z","data_as_of":null,"url":"https://www.findmykol.com/kol/brad-mcclimon","json_url":"https://www.findmykol.com/kol/brad-mcclimon/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"brad-mcclimon","name":"Brad McClimon","credential":"MD","specialty":"Allergy & Immunology","specialty_raw":"Allergy & Immunology","therapeutic_area":"Rheumatology/Immunology","therapeutic_areas":["Rheumatology/Immunology"],"city":"Dubuque","state":"IA","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1346450012","openalex":"A5024335695"},"summary":"Brad McClimon is a Rheumatology/Immunology physician. OpenAlex indexes 11 publications with 1,335 citations (h-index 5).","overview":null,"focus":{"indications":[],"research_topics":["Rheumatology/Immunology"]},"scholarship":{"works_count":11,"cited_by_count":1335,"h_index":5,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":3,"shown":3,"withheld":0,"rows":[{"payer":"SANOFI-AVENTIS U.S. LLC","program_year":2025,"amount_usd":99.95,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1346450012"},{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2024,"amount_usd":23.32,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1346450012"},{"payer":"SANOFI-AVENTIS U.S. LLC","program_year":2023,"amount_usd":57.48,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1346450012"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1346450012","source":"payments"},"prescribing":{"data_year":2024,"areas_total":5,"areas_shown":3,"areas":[{"area":"Respiratory","share_pct":81.4,"classes_total":6,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":43.7,"drugs":[{"name":"Fluticasone Propionate","share_pct":40.2},{"name":"Breo Ellipta","share_pct":16},{"name":"Arnuity Ellipta","share_pct":12.3},{"name":"Symbicort","share_pct":7.4},{"name":"Trelegy Ellipta","share_pct":5.7},{"name":"Breztri Aerosphere","share_pct":4.9},{"name":"Budesonide-Formoterol Fumarate","share_pct":4.9},{"name":"Breyna","share_pct":2.3},{"name":"Qvar Redihaler","share_pct":2.3},{"name":"Budesonide","share_pct":2.2},{"name":"Dulera","share_pct":1.8}],"max_beneficiaries":null},{"class":"Leukotriene Receptor Antagonist","setting":"prescribed","share_pct":18.9,"drugs":[{"name":"Montelukast Sodium","share_pct":100}],"max_beneficiaries":55}]},{"area":"Metabolism & gastrointestinal","share_pct":8.4,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":8.4,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":57}]},{"area":"Anti-infectives","share_pct":5.4,"classes_total":4,"classes":[{"class":"Tetracycline-class Drug","setting":"prescribed","share_pct":1.8,"drugs":[{"name":"Doxycycline Monohydrate","share_pct":51.9},{"name":"Doxycycline Hyclate","share_pct":48.1}],"max_beneficiaries":null},{"class":"Cephalosporin Antibacterial","setting":"prescribed","share_pct":1.7,"drugs":[{"name":"Cefdinir","share_pct":52},{"name":"Cefuroxime","share_pct":48}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"publications":{"total":11,"shown":5,"withheld":6,"matched_by":"OpenAlex author record","recent":[{"title":"Game Changers? MACRA, APM, The Future of the ACA: Where does the allergist go from here?","year":2017,"journal":"2017 AAAAI Annual Meeting","status":"verified"},{"title":"The predictive value of skin testing in the diagnosis of local anesthetic allergy","year":2011,"journal":"Allergy and Asthma Proceedings","source_url":"https://doi.org/10.2500/aap.2011.32.3417","status":"verified"},{"title":"XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease","year":2010,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2010-01-256099","status":"verified"},{"title":"Collaboration between Allergists and Pharmacists Increases β-Lactam Antibiotic Prescriptions in Patients with a History of Penicillin Allergy","year":2010,"journal":"International Archives of Allergy and Immunology","source_url":"https://doi.org/10.1159/000319209","status":"verified"},{"title":"RESOLUTION OF HYPOGAMMAGLOBULINEMIA AFTER RESECTION OF RENAL CELL CARCINOMA","year":2009,"journal":"Annals of Allergy Asthma & Immunology","source_url":"https://doi.org/10.1016/s1081-1206(10)60097-x","status":"verified"}],"source":"works"},"contact":{"address_1":"1500 ASSOCIATES DR","city":"Dubuque","state":"IA","zip":"520022201","phone":"563-584-4485","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1346450012","source":"identity"},"similar":[{"name":"David Felson","slug":"david-felson","institution":"Boston University","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/david-felson","json_url":"https://www.findmykol.com/kol/david-felson/profile.json"},{"name":"Marc Hochberg","slug":"marc-hochberg","institution":"University of Maryland School of Medicine","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/marc-hochberg","json_url":"https://www.findmykol.com/kol/marc-hochberg/profile.json"},{"name":"Philip Mease","slug":"philip-mease","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/philip-mease","json_url":"https://www.findmykol.com/kol/philip-mease/profile.json"},{"name":"Michelle Petri","slug":"michelle-petri","institution":"Johns Hopkins University School of Medicine","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/michelle-petri","json_url":"https://www.findmykol.com/kol/michelle-petri/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":6}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2009-07-07","collected_at":"2026-11-05T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}